Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 285(42): 32522-8, 2010 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-20716522

RESUMO

Temperature (T) reduction increases lifespan, but the mechanisms are not understood. Because reactive oxygen species (ROS) contribute to aging, we hypothesized that lowering T might decrease mitochondrial ROS production. We measured respiratory response and ROS production in isolated mitochondria at 32, 35, and 37 °C. Lowering T decreased the rates of resting (state 4) and phosphorylating (state 3) respiration phases. Surprisingly, this respiratory slowdown was associated with an increase of ROS production and hydrogen peroxide release and with elevation of the mitochondrial membrane potential, ΔΨ(m). We also found that at lower T mitochondria produced more carbon-centered lipid radicals, a species known to activate uncoupling proteins. These data indicate that reduced mitochondrial ROS production is not one of the mechanisms mediating lifespan extension at lower T. They suggest instead that increased ROS leakage may mediate mitochondrial responses to hypothermia.


Assuntos
Respiração Celular/fisiologia , Temperatura Baixa , Metabolismo Energético , Mitocôndrias/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Animais , Expectativa de Vida , Masculino , Camundongos , Camundongos Endogâmicos C57BL
2.
J Neuroimmunol ; 207(1-2): 92-100, 2009 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-19167097

RESUMO

The chemokine CXCL10 is expressed in the central nervous system (CNS) during neuroinflammatory conditions. Neurons express CXCR3, the receptor for CXCL10, and neuronal function has been shown to be altered by acute exposure to CXCL10. Little is known about the effects of chronic exposure to CXCL10 on neuronal function. Results from our studies show that chronic exposure of cultured rat hippocampal neurons to CXCL10 results in altered levels of protein for GABA and glutamate receptors and altered synaptic network activity. These effects of CXCL10 may contribute to altered CNS function that occurs in some chronic neuroinflammatory conditions.


Assuntos
Quimiocina CXCL10/farmacologia , Hipocampo/citologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Animais , Anticorpos/farmacologia , Baclofeno/farmacologia , Cálcio/metabolismo , Células Cultivadas , Relação Dose-Resposta a Droga , Embrião de Mamíferos , Agonistas GABAérgicos/farmacologia , Antagonistas GABAérgicos/farmacologia , Proteína Glial Fibrilar Ácida/metabolismo , Glutamato Descarboxilase/metabolismo , N-Metilaspartato/farmacologia , Ácidos Fosfínicos/farmacologia , Propanolaminas/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de AMPA/metabolismo , Receptores de GABA/imunologia , Receptores de GABA/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Sinapsinas/metabolismo , Fatores de Tempo
3.
J Neuroimmunol ; 195(1-2): 36-46, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18329727

RESUMO

Signal transduction pathways may be important targets of chemokines during neuroinflammation. In the current study, Western blot analyses show that in rat hippocampal neuronal/glial cell cultures chronic CXCL10 increases the level of protein for ERK1/2 as well as for the transcriptional factors CREB and NF-kappaB. Bcl-2, an anti-apoptotic protein whose expression can be regulated by a pathway involving ERK1/2, CREB and NF-kappaB, was also increased in the CXCL10 treated cultures. These results implicate a role for ERK1/2, CREB and NF-kappaB in effects of CXCL10 on hippocampal cells and suggest that chronic CXCL10 may have a protective role during certain neuroinflammatory conditions.


Assuntos
Proteína de Ligação a CREB/metabolismo , Quimiocina CXCL10/farmacologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Hipocampo/citologia , NF-kappa B/metabolismo , Neurônios/efeitos dos fármacos , Actinas/metabolismo , Análise de Variância , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Embrião de Mamíferos , Ativação Enzimática/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Fosfopiruvato Hidratase/metabolismo , Ratos , Ratos Sprague-Dawley
4.
Eur J Neurosci ; 25(12): 3605-16, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17610580

RESUMO

There is now considerable evidence that the level of expression of the proinflammatory cytokine, interleukin-6 (IL-6), is increased in the central nervous system (CNS) during neuroinflammatory conditions such as occurs in neurological disorders and in disease and injury. However, our understanding of the consequences of increased expression of IL-6 on the CNS is still limited, especially with respect to the developing nervous system, which is known to be particularly vulnerable to environmental factors. To address this issue, we investigated the properties of cultured hippocampal neurons exposed chronically to IL-6 during the main period of morphological and physiological development, which occurs during the first 2 weeks of culture. IL-6 was tested at 500 U/mL, considered to reflect a pathophysiologic concentration. The morphological features of neuronal development in the control and IL-6-treated cultures appeared similar. However, Western blot analysis showed a significant reduction in the level of Group-II metabotropic receptors (mGluR2/3) and L-type Ca(2+) channels in the IL-6-treated cultures. A similar reduction in mGluR2/3 and L-type Ca(2+) channel protein was observed in transgenic mice that over-express IL-6 in the CNS through astrocyte production starting early in development. Analysis of Ca(2+) signals produced by spontaneous synaptic network activity in the hippocampal cultures and effects of a mGluR2/3 agonist and antagonist showed that the reduced levels of mGluR2/3 impact on the functional properties of hippocampal synaptic network activity. These results have important implications relative to the mechanisms responsible for altered CNS function during conditions associated with increased levels of IL-6 in the CNS.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/metabolismo , Interleucina-6/farmacologia , Proteínas do Tecido Nervoso/metabolismo , Neurônios/efeitos dos fármacos , Sinapses/efeitos dos fármacos , Animais , Cálcio/metabolismo , Canais de Cálcio Tipo L/metabolismo , Células Cultivadas , Interações Medicamentosas , Embrião de Mamíferos , Antagonistas de Aminoácidos Excitatórios/farmacologia , Hipocampo/citologia , Interleucina-6/genética , Camundongos , Camundongos Transgênicos , Neurônios/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de Glutamato/metabolismo , Sinapses/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...